SA
BMY icon

Sanctuary Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Sanctuary Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.7M Buy
358,571
+19,316
+6% +$1.13M 0.12% 190
2025
Q4 		$18.3M Buy
339,255
+6,403
+2% +$308K 0.1% 211
2025
Q3 		$15M Buy
332,852
+20,403
+7% +$953K 0.09% 239
2025
Q2 		$14.5M Sell
312,449
-23,381
-7% -$1.15M 0.09% 235
2025
Q1 		$20.5M Sell
335,830
-7,234
-2% -$422K 0.14% 163
2024
Q4 		$20.3M Buy
343,064
+22,388
+7% +$1.25M 0.13% 173
2024
Q3 		$18.9M Buy
320,676
+143,743
+81% +$6.74M 0.12% 187
2024
Q2 		$7.94M Buy
+176,933
New +$7.92M 0.06% 335

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sanctuary Advisors's BMY Position: Q1 2026 in Review

Sanctuary Advisors increased its Bristol-Myers Squibb (BMY) stake by 5.7% in Q1 2026, buying an estimated $1.13M and bringing the position to 358,571 shares worth $21.7M. The position accounts for 0.12% of the portfolio, ranked #190.

Sanctuary Advisors first reported a position in BMY in Q2 2024 and has held it in 8 quarters since. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Sanctuary Advisors held 358,571 shares of Bristol-Myers Squibb worth $21.7M as of Q1 2026.
  • Sanctuary Advisors bought 19,316 Bristol-Myers Squibb shares in Q1 2026, an estimated $1.13M.
  • Bristol-Myers Squibb made up 0.12% of Sanctuary Advisors's portfolio in Q1 2026, its #190 holding.
  • Sanctuary Advisors first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 8 quarters since.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Sanctuary Advisors's 13F filing for Q1 2026, filed 5 May 2026.